Dr. Brian Czerniecki, MD – Tampa, FL

Overview of Dr. Czerniecki

I am Chair if Breast Oncology with strong laboratory research and leadership skills.

Education & Training

• Ohio State University HospitalResidency, Surgery, 1988 - 1993

• Rutgers Robert Wood Johnson Medical SchoolClass of 1988

Certifications & Licensure

• FL State Medical License 2016 - 2025

• PA State Medical License 1995 - 2016

• OH State Medical License 1989 - 1996

• American Board of Surgery Surgery

Awards, Honors, & Recognition

• America's Top Doctors Castle Connolly, 2013-2014
• Philadelphia Magazine Castle Connolly, 2012-2014
• America's Top Doctors for Cancer Castle Connolly, 2012-2013
• Join now to see all

Clinical Trials

Publications & Presentations

PubMed

• Reviewing the significance of dendritic cell vaccines in interrupting breast cancer development.

  Gautam, N., Ramamoorthi, G., Champion, N., Han, H., Czerniecki, B.> ;Molecular Aspects of Medicine. 2024 Feb 1
• 12 citations

  Oncolytic T-VEC virotherapy plus neoadjuvant chemotherapy in nonmetastatic triple-negative breast cancer: a phase 2 trial.

  Hatem Soliman, Deanna Hogue, Hyo Han, Blaise Mooney, Ricardo Costa, Marie C Lee, Bethany Niell, Angela Williams, Alec Chau, Shannon Falcon, Aixa Soyano, Avan Armaghani...> ;Nature Medicine. 2023 Feb 1
• 20 citations

  Ablation of the endoplasmic reticulum stress kinase PERK induces paraptosis and type I interferon to promote anti-tumor T cell responses.

  Jessica K Mandula, Shiun Chang, Eslam Mohamed, Rachel Jimenez, Rosa A Sierra-Mondragon, Darwin C Chang, Alyssa N Obermayer, Carlos M Moran-Segura, Satyajit Das, Julio ...> ;Cancer Cell. 2022 Oct 10
• Join now to see all

Journal Articles

• Feasibility of Radar Reflector Localization of Biopsy Proven Axillary Metastasis After Neoadjuvant Chemotherapy  

  Marie C Lee, John V Kiluk, Susan J Hoover, Brian J Czerniecki, Nazanin Khakpour, Journal of The American College of Surgeons

• Immune Interconnectivity of Anatomically Distant Tumors as a Potential Mediator of Systemic Responses to Local Therapy  

  Sungjune Kim, Eduardo G. Moros, Brian J. Czerniecki, Nature

Authored Content

Press Mentions

• Vaccinex and Its Collaborators Present Two Abstracts Related to Pepinemab Combination Immunotherapy Trials at 37th Annual Meeting of Society for Immunotherapy of CancerNovember 10th, 2022

• A No B.S Guide to What to Look for When Giving Yourself a Breast ExamSeptember 28th, 2022

• Moffitt Researchers Develop HER3-Specific Dendritic Cell Cancer VaccineDecember 1st, 2021

• Join now to see all

Grant Support

• A Her-2/Neu Pulsed DC1 Vaccine For Patients With DCISNational Cancer Institute2003–2012
• Upcc 08102: A Her-2/Neu Pulsed DC1 Vaccine For Patients With DCISNational Center For Research Resources2005

Research History

• Mason ChairResearch Chair in Breast Oncology2016 - Present

Professional Memberships

Hospital Affiliations

Insurance Accepted

• Aetna Choice POS II
  Aetna HMO
  AmeriHealth Direct POS
  Amerihealth HMO
  AmeriHealth PPO
  BCBS Blue Card PPO
  CIGNA HMO
  CIGNA Open Access
  CIGNA PPO
  Coventry Carelink Health Plans PPO
  First Choice
  First Health PPO
  GHI PPO
  Great West PPO
  HealthAmerica HealthAssurance PPO
  Horizon BCBS Direct Access
  

  Horizon BCBS HMO
  Horizon BCBS POS
  Horizon BCBS PPO
  Humana ChoiceCare Network PPO
  IBC Keystone HMO / POS
  IBC Personal Choice PPO
  Multiplan PPO
  ODS Network
  Oxford Health Freedom
  Oxford Health Liberty
  Premera BCBS Heritage & Heritage Plus 1
  Providence Health System Personal Option
  QualCare HMO
  QualCare PPO
  United Healthcare - Direct Choice Plus POS
  United Healthcare - Direct Options PPO
  

• Please verify your coverage with the provider's office directly when scheduling an appointment